Dnca Finance »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Dnca Finance

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Dnca Finance from 13F filings

Historical chart of Dnca Finance investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Dnca Finance consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Dnca Finance

Quarter filed Position value Share count Share price at filing
2025-09-30 $887k 630k 1.41
2025-06-30 $721k 630k 1.14
2025-03-31 $809k 630k 1.28
2024-12-31 $684k 630k 1.09
2024-09-30 $477k 400k 1.19